Revvity, INC. (RVTY) — SEC Filings

Overview

Revvity, INC. (RVTY) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 4, 2025: Revvity, Inc. reported a net income of $46.652 million for the three months ended September 28, 2025, a significant decrease from $94.367 million in the prior year period. Total revenue increased slightly to $698.949 million from $684.049 million year-over-year, driven by a rise in service revenue t

Sentiment Summary

Across 35 filings, the sentiment breakdown is: 2 bearish, 32 neutral, 1 mixed. The dominant filing sentiment for Revvity, INC. is neutral.

Filing Type Overview

Revvity, INC. (RVTY) has filed 6 10-Q, 15 8-K, 2 DEF 14A, 2 10-K, 8 SC 13G/A, 2 SC 13G with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (35)

• Revvity's Q3 Net Income Halves Amid Soaring Interest Expenses — 10-Q · Nov 4, 2025 Risk: high
  Revvity, Inc. reported a net income of $46.652 million for the three months ended September 28, 2025, a significant decrease from $94.367 million in the prior y
• Revvity, Inc. Files 8-K on Financials — 8-K · Oct 27, 2025 Risk: low
  Revvity, Inc. filed an 8-K on October 27, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exh
• Revvity, Inc. Files 8-K: Board & Executive Changes — 8-K · Oct 24, 2025 Risk: medium
  On October 23, 2025, Revvity, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates
• REVVITY Q2: Service Revenue Up, Product Sales Dip Amid Market Headwinds — 10-Q · Aug 5, 2025 Risk: medium
  REVVITY, INC. (RVTY) reported a mixed financial performance for the second quarter ended June 29, 2025. Product revenue for the quarter decreased to $X.XB from
• Revvity, Inc. Files 8-K on Financials — 8-K · Jul 28, 2025 Risk: low
  Revvity, Inc. filed an 8-K on July 28, 2025, reporting on its financial condition and results of operations. The filing includes financial statements and exhibi
• 10-Q Filing — 10-Q · May 6, 2025
• Revvity, Inc. Files 8-K on Financials — 8-K · Apr 28, 2025 Risk: low
  Revvity, Inc. filed an 8-K on April 28, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and
• Revvity, Inc. Files 8-K: Fiscal Year Change & Shareholder Vote — 8-K · Apr 25, 2025 Risk: low
  Revvity, Inc. filed an 8-K on April 25, 2025, reporting events as of April 22, 2025. The filing indicates a change in fiscal year and submission of matters to a
• Revvity Inc. Files DEF 14A for Executive Compensation — DEF 14A · Mar 12, 2025 Risk: medium
  Revvity, Inc. filed its DEF 14A on March 12, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 29, 202
• Revvity, Inc. Reports 2024 Financials — 10-K · Feb 25, 2025 Risk: medium
  Revvity, Inc. filed its 2024 10-K report on February 25, 2025, detailing its fiscal year ending December 29, 2024. The company reported total assets of $12,871,
• Revvity, Inc. Files 8-K on Financials — 8-K · Jan 31, 2025 Risk: low
  Revvity, Inc. filed an 8-K on January 31, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exh
• Revvity, Inc. Files 8-K on Financials — 8-K · Jan 13, 2025 Risk: low
  Revvity, Inc. filed an 8-K on January 13, 2025, reporting results of operations and financial condition as of January 12, 2025. The filing also includes a Regul
• Revvity, Inc. Files 8-K on Agreement Termination & Financial Obligation — 8-K · Jan 7, 2025 Risk: medium
  On January 7, 2025, Revvity, Inc. filed an 8-K report detailing the termination of a material definitive agreement and the creation of a direct financial obliga
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Revvity, Inc. Q3 2024 10-Q Filing — 10-Q · Nov 6, 2024 Risk: medium
  Revvity, Inc. filed its 10-Q for the period ending September 29, 2024. The company reported total assets of $122,091,000 and total liabilities of $123,426,000 f
• Revvity, Inc. Files 8-K on Financials — 8-K · Nov 4, 2024 Risk: low
  Revvity, Inc. filed an 8-K on November 4, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements an
• Revvity Reports Q2 2024 Results — 10-Q · Aug 6, 2024 Risk: medium
  Revvity, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $1,000,000,000 and total liabilities of $300,000,000. For
• Revvity, Inc. Files 8-K on Financials — 8-K · Jul 29, 2024 Risk: low
  On July 29, 2024, Revvity, Inc. filed an 8-K report detailing its financial results and condition. The filing includes information on its operations and financi
• Revvity, Inc. Files 10-Q for Q1 2024 — 10-Q · May 7, 2024 Risk: low
  REVVITY, INC. (RVTY) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Revvity, Inc. reported financial results for the period ending March 31, 2024.
• Revvity Sells Applied Genomics for ~$1B — 8-K · Apr 29, 2024 Risk: medium
  Revvity, Inc. announced on April 29, 2024, that it has completed the divestiture of its Applied Genomics business to an affiliate of Roark Capital. This transac
• Revvity, Inc. Reports on Shareholder Vote Matters — 8-K · Apr 24, 2024 Risk: low
  Revvity, Inc. filed an 8-K on April 24, 2024, reporting on matters submitted to a vote of its security holders on April 23, 2024. The filing indicates that the
• Revvity, Inc. Schedules 2024 Annual Meeting of Shareholders — DEF 14A · Mar 13, 2024 Risk: low
  REVVITY, INC. (RVTY) filed a Proxy Statement (DEF 14A) with the SEC on March 13, 2024. Revvity, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 13, 2
• Revvity, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024 Risk: medium
  REVVITY, INC. (RVTY) filed a Annual Report (10-K) with the SEC on February 27, 2024. Revvity, Inc. reported total assets of $14,697,780,722 for the fiscal year
• SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Capital Research Global Investors Amends Revvity Stake — SC 13G/A · Feb 9, 2024 Risk: low
  Capital Research Global Investors, a Delaware-based investment firm, filed an amended Schedule 13G/A on February 9, 2024, indicating their ownership of Revvity,
• Revvity 8-K Confirms Financial Condition, 1.875% Notes Due 2026 — 8-K · Feb 1, 2024
  Revvity, Inc. filed an 8-K on February 1, 2024, to report on its financial condition and results of operations. This filing indicates that the company's 1.875%
• Revvity 8-K Signals Potential Leadership/Comp Changes — 8-K · Jan 26, 2024
  Revvity, Inc. filed an 8-K on January 26, 2024, reporting an event that occurred on January 25, 2024, related to the departure or election of directors or offic
• BlackRock Amends Revvity Stake to 12.0% as of Dec 31, 2023 — SC 13G/A · Jan 26, 2024
  BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating a change in its ownership of REVVITY, INC. common stock as of December 31, 2023.
• Revvity to Present at J.P. Morgan Healthcare Conference — 8-K · Jan 9, 2024
  Revvity, Inc. filed an 8-K on January 9, 2024, to announce that it will be participating in the 42nd Annual J.P. Morgan Healthcare Conference. This is a signifi

Related Companies

PKI · TMO · DHR

Frequently Asked Questions